Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Comparison of the Effect on Glycemic Control of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Combination With Metformin in Subjects With Type 2 Diabetes
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
Alabama
-
Birmingham, Alabama, Forenede Stater, 35235
- Novo Nordisk Investigational Site
-
Tuscaloosa, Alabama, Forenede Stater, 35406
- Novo Nordisk Investigational Site
-
Vestavia, Alabama, Forenede Stater, 35209
- Novo Nordisk Investigational Site
-
-
Arkansas
-
Searcy, Arkansas, Forenede Stater, 72143
- Novo Nordisk Investigational Site
-
-
California
-
Chula Vista, California, Forenede Stater, 91911
- Novo Nordisk Investigational Site
-
Fullerton, California, Forenede Stater, 92835
- Novo Nordisk Investigational Site
-
Orange, California, Forenede Stater, 92869
- Novo Nordisk Investigational Site
-
Orange, California, Forenede Stater, 92868
- Novo Nordisk Investigational Site
-
-
Connecticut
-
New Britain, Connecticut, Forenede Stater, 06050
- Novo Nordisk Investigational Site
-
-
Florida
-
Aventura, Florida, Forenede Stater, 33180
- Novo Nordisk Investigational Site
-
Chiefland, Florida, Forenede Stater, 32626
- Novo Nordisk Investigational Site
-
Fort Myers, Florida, Forenede Stater, 33907
- Novo Nordisk Investigational Site
-
Jacksonville, Florida, Forenede Stater, 32208
- Novo Nordisk Investigational Site
-
Melbourne, Florida, Forenede Stater, 32901
- Novo Nordisk Investigational Site
-
Ocala, Florida, Forenede Stater, 34471
- Novo Nordisk Investigational Site
-
Plantation, Florida, Forenede Stater, 33324
- Novo Nordisk Investigational Site
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30339
- Novo Nordisk Investigational Site
-
Atlanta, Georgia, Forenede Stater, 30303
- Novo Nordisk Investigational Site
-
-
Idaho
-
Boise, Idaho, Forenede Stater, 83702
- Novo Nordisk Investigational Site
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60607
- Novo Nordisk Investigational Site
-
-
Indiana
-
New Albany, Indiana, Forenede Stater, 47150
- Novo Nordisk Investigational Site
-
-
Iowa
-
Des Moines, Iowa, Forenede Stater, 50314
- Novo Nordisk Investigational Site
-
-
Kansas
-
Overland Park, Kansas, Forenede Stater, 66209
- Novo Nordisk Investigational Site
-
Topeka, Kansas, Forenede Stater, 66606
- Novo Nordisk Investigational Site
-
-
Louisiana
-
Baton Rouge, Louisiana, Forenede Stater, 70808
- Novo Nordisk Investigational Site
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21204
- Novo Nordisk Investigational Site
-
-
Massachusetts
-
Springfield, Massachusetts, Forenede Stater, 01107
- Novo Nordisk Investigational Site
-
-
Missouri
-
Chesterfield, Missouri, Forenede Stater, 63017
- Novo Nordisk Investigational Site
-
St. Louis, Missouri, Forenede Stater, 63141
- Novo Nordisk Investigational Site
-
St. Louis, Missouri, Forenede Stater, 63017
- Novo Nordisk Investigational Site
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68114
- Novo Nordisk Investigational Site
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89119-6100
- Novo Nordisk Investigational Site
-
-
New Jersey
-
Cherry Hill, New Jersey, Forenede Stater, 08034
- Novo Nordisk Investigational Site
-
Lawrenceville, New Jersey, Forenede Stater, 08648
- Novo Nordisk Investigational Site
-
Plainsboro, New Jersey, Forenede Stater, 08536
- Novo Nordisk Investigational Site
-
-
New York
-
New Hyde Park, New York, Forenede Stater, 11042
- Novo Nordisk Investigational Site
-
Staten Island, New York, Forenede Stater, 10305
- Novo Nordisk Investigational Site
-
Syracuse, New York, Forenede Stater, 13210
- Novo Nordisk Investigational Site
-
-
North Carolina
-
Greensboro, North Carolina, Forenede Stater, 27408
- Novo Nordisk Investigational Site
-
-
Ohio
-
Dayton, Ohio, Forenede Stater, 45439
- Novo Nordisk Investigational Site
-
Dayton, Ohio, Forenede Stater, 45406
- Novo Nordisk Investigational Site
-
Kettering, Ohio, Forenede Stater, 45429
- Novo Nordisk Investigational Site
-
-
Oklahoma
-
Clinton, Oklahoma, Forenede Stater, 73601
- Novo Nordisk Investigational Site
-
Tulsa, Oklahoma, Forenede Stater, 74104
- Novo Nordisk Investigational Site
-
-
Oregon
-
Eugene, Oregon, Forenede Stater, 97401
- Novo Nordisk Investigational Site
-
Portland, Oregon, Forenede Stater, 97239
- Novo Nordisk Investigational Site
-
Salem, Oregon, Forenede Stater, 97302
- Novo Nordisk Investigational Site
-
-
Pennsylvania
-
Lancaster, Pennsylvania, Forenede Stater, 17601
- Novo Nordisk Investigational Site
-
Melrose Park, Pennsylvania, Forenede Stater, 19027
- Novo Nordisk Investigational Site
-
Norristown, Pennsylvania, Forenede Stater, 19401
- Novo Nordisk Investigational Site
-
West Reading, Pennsylvania, Forenede Stater, 19611
- Novo Nordisk Investigational Site
-
-
South Carolina
-
Greer, South Carolina, Forenede Stater, 29651
- Novo Nordisk Investigational Site
-
-
Tennessee
-
Memphis, Tennessee, Forenede Stater, 38115
- Novo Nordisk Investigational Site
-
-
Texas
-
Arlington, Texas, Forenede Stater, 76014
- Novo Nordisk Investigational Site
-
Dallas, Texas, Forenede Stater, 75230
- Novo Nordisk Investigational Site
-
Dallas, Texas, Forenede Stater, 75231
- Novo Nordisk Investigational Site
-
Dallas, Texas, Forenede Stater, 75390-8858
- Novo Nordisk Investigational Site
-
Dallas, Texas, Forenede Stater, 75246
- Novo Nordisk Investigational Site
-
Dallas, Texas, Forenede Stater, 75208
- Novo Nordisk Investigational Site
-
Houston, Texas, Forenede Stater, 77030
- Novo Nordisk Investigational Site
-
Lewisville, Texas, Forenede Stater, 75067
- Novo Nordisk Investigational Site
-
Midland, Texas, Forenede Stater, 79707
- Novo Nordisk Investigational Site
-
Plano, Texas, Forenede Stater, 75093
- Novo Nordisk Investigational Site
-
Plano, Texas, Forenede Stater, 75074
- Novo Nordisk Investigational Site
-
San Antonio, Texas, Forenede Stater, 78229
- Novo Nordisk Investigational Site
-
-
Utah
-
Ogden, Utah, Forenede Stater, 84403
- Novo Nordisk Investigational Site
-
-
Virginia
-
Newport News, Virginia, Forenede Stater, 23606
- Novo Nordisk Investigational Site
-
Richmond, Virginia, Forenede Stater, 23249
- Novo Nordisk Investigational Site
-
Warrenton, Virginia, Forenede Stater, 20186
- Novo Nordisk Investigational Site
-
-
Washington
-
Bellevue, Washington, Forenede Stater, 98004
- Novo Nordisk Investigational Site
-
-
Wisconsin
-
Milwaukee, Wisconsin, Forenede Stater, 53209
- Novo Nordisk Investigational Site
-
-
-
-
-
Manati, Puerto Rico, 00674
- Novo Nordisk Investigational Site
-
Santurce, Puerto Rico, 00907
- Novo Nordisk Investigational Site
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Type 2 Diabetes
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
HbA1c
Tidsramme: After 24 weeks
|
After 24 weeks
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
|---|
|
safety variables
|
|
other glycemic variables
|
|
8-point plasma glucose profile
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Publikationer og nyttige links
Generelle publikationer
- Ligthelm RJ, Gylvin T, DeLuzio T, Raskin P. A comparison of twice-daily biphasic insulin aspart 70/30 and once-daily insulin glargine in persons with type 2 diabetes mellitus inadequately controlled on basal insulin and oral therapy: a randomized, open-label study. Endocr Pract. 2011 Jan-Feb;17(1):41-50. doi: 10.4158/EP10079.OR.
- Oyer DS, Shepherd MD, Coulter FC, Bhargava A, Deluzio AJ, Chu PL, Trippe BS; Initiateplus Study Group. Efficacy and tolerability of self-titrated biphasic insulin aspart 70/30 in patients aged >65 years with type 2 diabetes: an exploratory post hoc subanalysis of the INITIATEplus trial. Clin Ther. 2011 Jul;33(7):874-83. doi: 10.1016/j.clinthera.2011.05.093. Epub 2011 Jul 8.
- Trippe BS, Shepherd MD, Coulter FC, Bhargava A, Brett J, Chu PL, Oyer DS. Efficacy and safety of biphasic insulin aspart 70/30 in type 2 diabetes patients of different race or ethnicity (INITIATEplus trial). Curr Med Res Opin. 2012 Jul;28(7):1203-11. doi: 10.1185/03007995.2012.686444. Epub 2012 Jun 25.
- Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951.
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- BIASP-2191
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .